Protalix Biotherapeutics Inc (PLX)
Cost of Revenue
$7.76M
Quarterly · Period ending: · USD
PLX Cost of Revenue
Latest reported$7.76Mperiod ending
Latest reported$7.76Mperiod ending
PLX Quarterly Cost of Revenue ($0.00 → $7.76M)
Quarterly cost of revenue
High-resolution chart · PNG
PLX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 7,762,000 | |
| 4,127,000 | |
| 4,619,000 | |
| 8,324,000 | |
| 5,870,000 | |
| 8,180,000 | |
| 3,886,000 | |
| 8,375,000 | |
| 9,456,000 | |
| 2,602,000 | |
| 8,856,000 | |
| 4,893,000 | |
| 6,148,000 | |
| 3,085,000 | |
| 2,397,000 | |
| 7,074,000 | |
| 4,087,000 | |
| 6,034,000 | |
| 3,148,000 | |
| 3,703,000 | |
| 4,733,000 | |
| 4,765,000 | |
| 2,752,000 | |
| 2,868,000 | |
| 1,827,000 | |
| 3,426,000 | |
| 2,950,000 | |
| 3,205,000 | |
| 2,695,000 | |
| 2,045,000 | |
| 2,278,000 | |
| 1,917,000 | |
| 2,183,000 | |
| 2,924,000 | |
| 1,554,000 | |
| 6,066,000 | |
| 5,523,000 | |
| 2,088,000 | |
| 1,952,000 | |
| 4,248,000 | |
| 1,675,000 | |
| 523,000 | |
| -6,055,000 | |
| 2,346,000 | |
| 225,000 | |
| 2,400,000 | |
| 1,577,000 | |
| 1,798,000 | |
| 1,605,000 | |
| 4,073,000 | |
| 1,552,000 | |
| 1,587,000 | |
| 1,318,000 | |
| 971,000 | |
| 1,178,000 | |
| 2,367,000 | |
| 3,279,000 | |
| 1,320,000 | |
| 2,068,000 | |
| 455,000 | |
| 132,000 | |
| 778,000 | |
| 7,098,000 | |
| 1,065,000 | |
| 0 | |
| 0 | |
| 3,575,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 35,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |